FR24C1000I1 - Formulation a liberation plurimodale a base de doxylamine et de pyridoxine et/ou de metabolites ou de sels associes - Google Patents

Formulation a liberation plurimodale a base de doxylamine et de pyridoxine et/ou de metabolites ou de sels associes

Info

Publication number
FR24C1000I1
FR24C1000I1 FR24C1000C FR24C1000C FR24C1000I1 FR 24C1000 I1 FR24C1000 I1 FR 24C1000I1 FR 24C1000 C FR24C1000 C FR 24C1000C FR 24C1000 C FR24C1000 C FR 24C1000C FR 24C1000 I1 FR24C1000 I1 FR 24C1000I1
Authority
FR
France
Prior art keywords
doxylamine
pyridoxine
metabolites
release formulation
formulation based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR24C1000C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duchesnay Inc
Original Assignee
Duchesnay Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duchesnay Inc filed Critical Duchesnay Inc
Publication of FR24C1000I1 publication Critical patent/FR24C1000I1/fr
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415Pyridoxine, i.e. Vitamin B6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR24C1000C 2014-08-29 2024-01-04 Formulation a liberation plurimodale a base de doxylamine et de pyridoxine et/ou de metabolites ou de sels associes Active FR24C1000I1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA2014/050828 WO2016029290A1 (fr) 2014-08-29 2014-08-29 Formulation à libération plurimodale à base de doxylamine et de pyridoxine et/ou de métabolites ou de sels associés

Publications (1)

Publication Number Publication Date
FR24C1000I1 true FR24C1000I1 (fr) 2024-02-23

Family

ID=55398524

Family Applications (1)

Application Number Title Priority Date Filing Date
FR24C1000C Active FR24C1000I1 (fr) 2014-08-29 2024-01-04 Formulation a liberation plurimodale a base de doxylamine et de pyridoxine et/ou de metabolites ou de sels associes

Country Status (25)

Country Link
EP (1) EP3185856B1 (fr)
JP (1) JP6272561B2 (fr)
KR (1) KR101831570B1 (fr)
CN (1) CN106794148B (fr)
AR (1) AR101728A1 (fr)
AU (1) AU2014405049B2 (fr)
CA (1) CA2920247C (fr)
CY (1) CY1120788T1 (fr)
DK (1) DK3185856T3 (fr)
EA (1) EA032671B1 (fr)
ES (1) ES2674996T3 (fr)
FR (1) FR24C1000I1 (fr)
HU (1) HUE038969T2 (fr)
IL (1) IL250541B (fr)
MX (1) MX360662B (fr)
MY (1) MY196073A (fr)
PH (1) PH12017500282B1 (fr)
PL (1) PL3185856T3 (fr)
PT (1) PT3185856T (fr)
SA (1) SA517380942B1 (fr)
SG (1) SG11201701448XA (fr)
TR (1) TR201809565T4 (fr)
UA (1) UA118711C2 (fr)
WO (1) WO2016029290A1 (fr)
ZA (1) ZA201701063B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3628311T (pt) 2018-09-27 2021-02-09 Inibsa Ginecologia S A Um processo para a preparação de uma forma de dosagem oral, de unidade múltipla de libertação modificada, de sucinato de doxilamina e cloridrato de piridoxina
AR121619A1 (es) 2020-03-25 2022-06-22 Inibsa Ginecologia S A Una forma de dosificación oral de múltiples unidades de liberación modificada de succinato de doxilamina y clorhidrato de piridoxina y un procedimiento para su preparación

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
CA2350195C (fr) * 2000-12-20 2003-06-10 Duchesnay Inc. Preparation a delai d'action rapide de chlorhydrate de pyridoxine et de doxylamine succinate
TWI292138B (en) * 2004-03-11 2008-01-01 Mstar Semiconductor Inc Device for adaptively adjusting video's luminance and related method
PT1814527E (pt) * 2004-11-05 2014-01-16 Boehringer Ingelheim Int Comprimido de bicamada compreendendo telmisartan e amlodipina
EP2408427A1 (fr) * 2009-03-20 2012-01-25 Novartis AG Formulations galéniques d'une combinaison de dose fixe de valsartan et d'aliskiren
EP2500016A1 (fr) * 2011-03-18 2012-09-19 Laboratorios Del. Dr. Esteve, S.A. Complexe de résinate de doxylamine
CA2761212A1 (fr) * 2011-12-07 2013-06-07 Pharmascience Inc. Formulation de pyridoxine et de doxylamine a action retardee sans delitant et son procede de fabrication
WO2013123595A1 (fr) * 2012-02-22 2013-08-29 Duchesnay Inc. Formulation de doxylamine et de pyridoxine et/ou de leurs métabolites ou sels
WO2013123569A1 (fr) * 2012-02-22 2013-08-29 Duchesnay Inc. Formulation à base de doxylamine et de pyridoxine et/ou de métabolites ou de sels associés

Also Published As

Publication number Publication date
EA032671B1 (ru) 2019-06-28
CN106794148B (zh) 2018-12-21
ZA201701063B (en) 2019-11-27
PT3185856T (pt) 2018-10-09
IL250541B (en) 2018-12-31
CA2920247A1 (fr) 2016-02-29
AU2014405049A1 (en) 2017-04-06
MX2017002495A (es) 2017-09-13
NZ729042A (en) 2021-01-29
JP2017525731A (ja) 2017-09-07
UA118711C2 (uk) 2019-02-25
MY196073A (en) 2023-03-13
AU2014405049B2 (en) 2017-04-20
CN106794148A (zh) 2017-05-31
JP6272561B2 (ja) 2018-01-31
BR112017004190A2 (pt) 2017-12-12
HUE038969T2 (hu) 2018-12-28
PH12017500282A1 (en) 2017-06-28
KR20170046163A (ko) 2017-04-28
IL250541A0 (en) 2017-03-30
EP3185856B1 (fr) 2018-05-23
DK3185856T3 (en) 2018-07-30
PL3185856T3 (pl) 2018-09-28
AR101728A1 (es) 2017-01-11
KR101831570B1 (ko) 2018-02-22
SG11201701448XA (en) 2017-03-30
PH12017500282B1 (en) 2017-06-28
ES2674996T3 (es) 2018-07-05
EP3185856A4 (fr) 2017-09-13
WO2016029290A1 (fr) 2016-03-03
SA517380942B1 (ar) 2021-05-16
EP3185856A1 (fr) 2017-07-05
MX360662B (es) 2018-11-13
CY1120788T1 (el) 2020-05-29
TR201809565T4 (tr) 2018-07-23
CA2920247C (fr) 2017-01-03
EA201790477A1 (ru) 2017-07-31

Similar Documents

Publication Publication Date Title
NO2022046I1 (no) Berotralstat and pharmaceutically acceptable salts thereof
DK3234380T3 (da) Paneler omfattende en mekanisk låseanordning
DK3134068T3 (da) Langtidsvirkende polymerafgivelsessystemer
DK2991380T3 (da) Hørehjælpeanordning der omfatter en placeringsidentifikationsenhed
DK3143047T3 (da) Belimumab-formulering
FR24C1000I1 (fr) Formulation a liberation plurimodale a base de doxylamine et de pyridoxine et/ou de metabolites ou de sels associes
DK3206518T3 (da) Footlet samt en fremgangsmåde til at fremstille en sådan footlet
DE112015000747A5 (de) Normal-eingerückte Kupplungsvorrichtung
SE1651579A1 (sv) A screw-retaining device
ZA201807416B (en) A storage device
EP3356931A4 (fr) Vérification d'exécution au moyen d'un dispositif externe
GB201720298D0 (en) A storage device
DK3118452T3 (da) Kit til en vindstation samt fremgangsmåde
GB2568565B (en) Precision positioning device
CL2016002705A1 (es) Formulación agroquímica
FR3018193B1 (fr) Comprime vaginal muco-adhesif a liberation prolongee
DK3154141T3 (da) Koblingsanordning
DE112016003436A5 (de) Release Liner
FR3051235B1 (fr) Palier a roulement
FR3021870B1 (fr) Composition dermatologique a base de niacinamide
DK3320822T3 (da) Sugeindretning med en tilslutningsindretning
SE1651494A1 (sv) Anchoring base
FR3053749B1 (fr) Palier a roulement
DK3509715T3 (da) Rouletteapparat
DK3194664T3 (da) Fremgangsmåde til at danne en gulvstruktur og fremgangsmåde til at danne et husfundament